Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02888301 · ClinicalTrials.gov registry record
18F-Clofarabine PET/CT in Imaging Cancer Patients Before and After Interventions
A clinical trial, sponsored by Jonsson Comprehensive Cancer Center.
- Terminated
- Registry status
- 12
- Enrollment target
NCT02888301 is a clinical trial that was terminated before completion, run by Jonsson Comprehensive Cancer Center. The registered enrollment target is 12 participants.
The verdict
NCT02888301 was terminated before completion, sponsored by Jonsson Comprehensive Cancer Center.
- TERMINATED
- Registry status
- 12 participants
- Enrollment target
Study Summary
This clinical trial studies 18F-clofarabine positron emission tomography (PET)/computed tomography (CT) in imaging patients with cancer before and after treatment with a therapy that activates the patient's immune system (immunotherapy). PET/CT scans give detailed pictures of areas inside the body. 18F-clofarabine is a drug that contains a radioactive substance that is taken up by cells expressing deoxycytidine kinase (dCK), which is highly expressed in activated immune cells, making them light up during PET/CT scans. Doctors also want to know how 18F-clofarabine is distributed throughout the body before and after treatment with immunotherapies.
Interventions
- PROCEDURE Computed Tomography
- PROCEDURE Positron Emission Tomography
- RADIATION Fluorine F 18 Clofarabine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2015-06-12 |
| Est. Completion | 2018-04-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02888301
The ClinicalTrials.gov registry entry for NCT02888301 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Jonsson Comprehensive Cancer Center, which has 321 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Computed Tomography is the first listed.
NCT02888301 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02888301 about?
NCT02888301 is a clinical study titled "18F-Clofarabine PET/CT in Imaging Cancer Patients Before and After Interventions". This clinical trial studies 18F-clofarabine positron emission tomography (PET)/computed tomography (CT) in imaging patients with cancer before and after treatment with a therapy that activates the patient's immune system (immunotherapy). PET/CT scans give detailed pictures of areas inside the body. ...
What is the current status of trial NCT02888301?
This trial is currently terminated. The enrollment target is 12 participants. The study started on 2015-06-12. Estimated completion is 2018-04-30.
What interventions are being tested in trial NCT02888301?
The interventions under investigation include: Computed Tomography (PROCEDURE), Positron Emission Tomography (PROCEDURE), Fluorine F 18 Clofarabine (RADIATION).
Who is sponsoring clinical trial NCT02888301?
This trial is sponsored by Jonsson Comprehensive Cancer Center, which has 321 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.